Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Centers for Research on Neglected Infectious Diseases

U.S. National Institutes of Health·United States of America

Centers for Research on Neglected Infectious Diseases

Closes 6/14/2027$300k – $1MGrants Notice
Get bids like this by emailBid source

Description

The National Institute of Allergy and Infectious Diseases (NIAID) is issuing a Request for Applications to fund up to eight Centers for Research on Neglected Infectious Diseases (CReNIDs). The program targets multidisciplinary research on understudied viral, bacterial, parasitic, and fungal diseases that disproportionately affect low‑resource regions. Funding will support epidemiology, pathogenesis, diagnostics, treatment, prevention, and capacity‑building in endemic countries, with the ultimate goal of protecting U.S. public health by strengthening global research infrastructure. Applicants may include state, local, tribal, nonprofit, for‑profit, and foreign entities that meet eligibility criteria. The total anticipated award ceiling is $4.2 million, averaging roughly $525 k per center, with awards expected to begin March 1 2028. • Focus on neglected infectious diseases (NIDs) – viral, bacterial, parasitic, fungal • Multidisciplinary research: epidemiology, pathogenesis, diagnostics, therapeutics, prevention • Capacity‑building component in endemic regions • Up to 8 awards; total estimated funding $4.2 M (≈$525 k per award) • Eligibility: wide range of public, private, tribal, and foreign entities • Forecast dates: posting 10/06/2026, application due 06/15/2027, award 03/01/2028, project start 03/01/2028

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

CreNID (Division of Microbiology and Infectious Diseases)

[email protected]

Key dates

Opened
10/6/2026
Closes
6/14/2027
Projected award
3/1/2028

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541714
Solicitation №
RFA-AI-28-020

Budget estimate

$300,000 – $1,000,000

The forecast lists total estimated funding of $4,200,000 for eight awards, averaging about $525,000 per center. Grants of this type typically range from $300,000 for smaller, focused centers up to $1,000,000 for larger, multi‑site programs, depending on scope, number of investigators, and infrastructure needs. Therefore a reasonable budget range for a successful applicant is $300k–$1M, with the midpoint reflecting the forecast average.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 86%

Partnerships for Advancing Development of Diagnostics for Infectious Diseases

Closes 10/13/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

86% match

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 5/28/2027Opened 12/22/2025

U.S. National Institutes of Health·United States of America

86% match

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 12/29/2025

U.S. National Institutes of Health·United States of America

85% match

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 11/18/2025

U.S. National Institutes of Health·United States of America

84% match

NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)

Closes 5/31/2027Opened 7/2/2026

U.S. National Institutes of Health·United States of America

84% match

Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 11/18/2025

U.S. National Institutes of Health·United States of America

84% match

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

84% match

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

Closes 6/20/2029Opened 11/18/2025

U.S. National Institutes of Health·United States of America

83% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

83% match

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/12/2025

U.S. Centers for Disease Control - NCHHSTP·United States of America

83% match

Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use

Closes 6/22/2027Opened 7/24/2026

U.S. National Institutes of Health·United States of America

83% match

Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource-Constrained Settings--Implementation Science Network (PATC3H-IN)

Closes 10/27/2027Opened 10/20/2026

U.S. National Institutes of Health·United States of America

83% match

Immune Tolerance Network (UM1 Clinical Trial Required)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

83% match

Asthma and Allergic Diseases Cooperative Research Centers

Closes 5/20/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

82% match

Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories

Closes 9/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

82% match

The Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes

Closes 10/12/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

82% match

Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)

Closes 2/10/2027Opened 9/2/2025

U.S. National Institutes of Health·United States of America

82% match

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 4/9/2026

U.S. National Institutes of Health·United States of America

82% match

CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect

Closes 9/30/2027Opened 10/20/2026

U.S. National Institutes of Health·United States of America

82% match

Learning Disabilities Research Centers

Closes 9/30/2027Opened 10/20/2026

U.S. Centers for Disease Control - OD·United States of America

82% match

National Foundation for the Centers for Disease Control and Prevention

Rolling / TBD closeOpened 8/6/2026

U.S. Department Of Health And Human Services·United States of America

81% match

2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases

Closes 12/8/2026Opened 10/9/2026

U.S. National Institutes of Health·United States of America

81% match

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Closes 9/25/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

81% match

Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)

Closes 1/24/2027Opened 7/16/2026

U.S. Centers for Disease Control - NCEZID·United States of America

81% match

DHQP Global NOFO

Closes 6/18/2027Opened 8/3/2026